about
Comparison of the effects of forefoot joint-preserving arthroplasty and resection-replacement arthroplasty on walking plantar pressure distribution and patient-based outcomes in patients with rheumatoid arthritis.Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study.Administration of Oxygen Ultra-Fine Bubbles Improves Nerve Dysfunction in a Rat Sciatic Nerve Crush Injury Model.Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis-the ANSWER cohort studyDrug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis -The ANSWER cohort studyImpact of switching oral bisphosphonates to denosumab or daily teriparatide on the progression of radiographic joint destruction in patients with biologic-naïve rheumatoid arthritisDrug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort studyThe family history of rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-positive patient is not a predictor of poor clinical presentation and treatment response with modern classification criteria and treatment strategy: the ANSWEREffects of follow-on therapy after denosumab discontinuation in patients with postmenopausal osteoporosisDrug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study
P50
Q41545296-C2EDD9DA-D411-4CA5-AA58-641BC412EB67Q52653996-71B6B94C-F550-4E78-9A95-2505EBC21C4AQ55088792-C75E77B6-BBFD-42BA-8482-40FB8DF60A0CQ64053097-C2A592A1-E760-4B3E-A47C-22A61C14B3BEQ64062693-26822697-94B3-4F0F-B6CD-C2AE4C9C0E09Q88160120-FF724D08-A325-47FF-AFD7-7A57B687D7ADQ90252950-99C85743-FA7D-400C-B28B-3CB4284CEC2DQ90761832-9175993E-970B-4AB3-B4C2-C160055255FDQ94931781-5906E1D0-F0E2-4801-A671-5ECB96F0E03FQ96354140-147ACB85-F93F-400A-89D4-38C53CD2A269
P50
description
researcher
@en
wetenschapper
@nl
name
Kosuke Ebina
@en
Kosuke Ebina
@nl
type
label
Kosuke Ebina
@en
Kosuke Ebina
@nl
prefLabel
Kosuke Ebina
@en
Kosuke Ebina
@nl
P31
P496
0000-0002-2426-1024